Wang L - Search Results

1

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Yao M, et al. Among authors: wang l, wang df. World J Clin Cases. 2022 Apr 16;10(11):3321-3333. doi: 10.12998/wjcc.v10.i11.3321. World J Clin Cases. 2022. PMID: 35611205 Free PMC article. Review.

2

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.

Wu MN, Zheng WJ, Ye WX, Wang L, Chen Y, Yang J, Yao DF, Yao M. Wu MN, et al. Among authors: wang l. World J Gastroenterol. 2021 Jun 21;27(23):3327-3341. doi: 10.3748/wjg.v27.i23.3327. World J Gastroenterol. 2021. PMID: 34163115 Free PMC article.

3

Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells.

Yao M, Cai Y, Wu ZJ, Zhou P, Sai WL, Wang DF, Wang L, Yao DF. Yao M, et al. Among authors: wang l, wang df. World J Clin Cases. 2022 Oct 6;10(28):10017-10030. doi: 10.12998/wjcc.v10.i28.10017. World J Clin Cases. 2022. PMID: 36246809 Free PMC article.

4

Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy.

Yao M, Wang L, Dong Z, Qian Q, Shi Y, Yu D, Wang S, Zheng W, Yao D. Yao M, et al. Among authors: wang l, wang s. Tumour Biol. 2014 Jun;35(6):5857-68. doi: 10.1007/s13277-014-1776-5. Epub 2014 Mar 16. Tumour Biol. 2014. PMID: 24633918

5

IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.

Yao M, Wang L, Yang J, Yan X, Cai Y, Yao D. Yao M, et al. Among authors: wang l. Tumour Biol. 2016 Nov;37(11):14677-14686. doi: 10.1007/s13277-016-5296-3. Epub 2016 Sep 13. Tumour Biol. 2016. PMID: 27623941

6

Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.

Yao M, Wang L, Fang M, Zheng W, Dong Z, Yao D. Yao M, et al. Among authors: wang l. Biosci Trends. 2016 Nov 15;10(5):337-343. doi: 10.5582/bst.2016.01176. Epub 2016 Oct 29. Biosci Trends. 2016. PMID: 27795482 Free article. Review.

7

Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.

Gu JJ, Yao M, Yang J, Cai Y, Zheng WJ, Wang L, Yao DB, Yao DF. Gu JJ, et al. Among authors: wang l. World J Gastroenterol. 2017 Jan 14;23(2):256-264. doi: 10.3748/wjg.v23.i2.256. World J Gastroenterol. 2017. PMID: 28127199 Free PMC article.

8

Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.

Wang L, Yao M, Fang M, Zheng WJ, Dong ZZ, Pan LH, Zhang HJ, Yao DF. Wang L, et al. Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):227-232. doi: 10.1016/j.hbpd.2018.03.005. Epub 2018 Mar 13. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29709351

9

Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.

Zheng WJ, Yao M, Fang M, Wang L, Dong ZZ, Yao DF. Zheng WJ, et al. Among authors: wang l. World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650. World J Gastroenterol. 2018. PMID: 30166860 Free PMC article.

10

Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.

Wang L, Yao M, Zheng W, Fang M, Wu M, Sun J, Dong Z, Yao D. Wang L, et al. Mini Rev Med Chem. 2019;19(4):272-280. doi: 10.2174/1389557518666181025151608. Mini Rev Med Chem. 2019. PMID: 30360707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,402 results

Search Page

Filters